Mineralys Therapeutics appoints Kristine Peterson and Lonnel Coats to board

MLYS•2026-10-19

Mineralys Therapeutics appointed Kristine Peterson and Lonnel Coats to its board as it prepares for lorundrostat's potential approval and commercial launch.

1. Board appointments

Mineralys Therapeutics appointed Kristine Peterson and Lonnel Coats to its board as it prepares for lorundrostat's potential approval and commercial launch. Peterson most recently served as CEO of Valeritas, while Coats most recently served as CEO of Lexicon Pharmaceuticals.

Mineralys Therapeutics appoints Kristine Peterson and Lonnel Coats to board

1. Board appointments

Related News

Fenbo Holdings says first-half 2026 net loss widened as costs outpaced revenue growth

Marriott Vacations Worldwide names Heena Patel chief revenue management officer

Solowin Holdings holds extraordinary shareholder meeting

Union Pacific defends Norfolk Southern deal benefits with detailed regulatory evidence

Texas Instruments announces dividend of R$ 0.3411576960 per unit